UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Cancer treatment center
5115 Centre Ave, Pittsburgh, PA 15232
About UPMC Hillman Cancer Center
The UPMC Hillman Cancer Center, previously titled the University of Pittsburgh Cancer Institute, is a National Cancer Institute-designated Comprehensive Cancer Center located in the Hillman Cancer Center in the Shadyside neighborhood of Pittsburgh, Pennsylvania, United States, adjacent to UPMC Shadyside.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Pittsburgh
46
Bristol-Myers Squibb
21
Eastern Cooperative Oncology Group
18
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
18
Pfizer
17
Alliance for Clinical Trials in Oncology
15
NSABP Foundation Inc
15
Celgene
14
Incyte Corporation
9
Diwakar Davar
7
Novartis Pharmaceuticals
7
Clinical Trials at UPMC Hillman Cancer Center
During the past decade, UPMC Hillman Cancer Center conducted 284 clinical trials. In the 10-year time frame, 284 clinical trials started and 129 clinical trials were completed, i.e. on
average, 45.4% percent of trials that started reached the finish line to date. In the past 5 years, 127 clinical trials started and 57 clinical trials were completed. i.e. 44.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
1994-12-01
2005-08-01
Completed
66
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
1996-06-01
2009-10-01
Completed
1,118
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
1998-01-01
Completed
4,000
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
1999-12-01
Completed
280
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UPMC Hillman Cancer Center" #1 sponsor was "University of Pittsburgh" with 46 trials, followed by "Bristol-Myers Squibb" with 21 trials
sponsored, "Eastern Cooperative Oncology Group" with 18 trials sponsored, "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 18 trials sponsored and "Pfizer"
with 18 trials sponsored. Other sponsors include 407 different institutions and
companies that sponsored additional 212 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 111 trials as a collaborator, "Merck Sharp & Dohme LLC" with 27 trials as a collaborator, "Bristol-Myers Squibb" with 23 trials as a collaborator, "Genentech, Inc." with 9 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 207 different institutions and companies that were
collaborators in the rest 134 trials.
Clinical Trials Conditions at UPMC Hillman Cancer Center
According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center" are
"Melanoma" (43 trials), "Breast Cancer" (33 trials), "Colorectal Cancer" (23 trials), "Lung Cancer" (20 trials) and "Prostate Cancer" (20 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at UPMC Hillman Cancer Center
Most popular intervention types in "UPMC Hillman Cancer Center" are "Drug" (430 trials), "Biological" (115 trials), "Radiation" (47 trials), "Other" (44 trials) and "Procedure" (40 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (35 trials), "Pembrolizumab" (26 trials), "Nivolumab" (25 trials), "Gemcitabine" (22 trials) and "radiation therapy" (16 trials). Other intervention names were less common.
Clinical Trials Genders at UPMC Hillman Cancer Center
The vast majority of trials in "UPMC Hillman Cancer Center" are
473 trials for "All" genders, 34 trials for "Female" genders and 25 trials for "Male" genders.
Clinical Trials Status at UPMC Hillman Cancer Center
Currently, there are 205 active trials in "UPMC Hillman Cancer Center".
2 are not yet recruiting,
121 are recruiting,
80 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 219 completed trials in UPMC Hillman Cancer Center,
4 suspended trials,
and 78 terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Hillman Cancer Center, 193 "Phase 1"
clinical trials were conducted, 269 "Phase 2" clinical
trials and 109 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 18 trials that are defined as “Not Applicable".